Prion disease: A tale of folds and strains

Brain Pathology

Volumn 23, Issue 3, 2013, Pages 321-332

  Kretzschmar, Hans ^a   Tatzelt, Jörg ^b,c  

^a Institut für Neuropathologie   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Creutzfeldt Jakob disease; prion diseases; prion strains; templated misfolding

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN;

BIOGENESIS; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; FAMILIAL DISEASE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN PROCESSING; TOXICITY; VIRUS INFECTIVITY;

ANIMALS; BLOOD-BRAIN BARRIER; CREUTZFELDT-JAKOB SYNDROME; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KURU; PRION DISEASES; PROTEIN FOLDING; PROTEOSTASIS DEFICIENCIES; PRPC PROTEINS;

EID: 84876271672     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12045     Document Type: Conference Paper

References (197)

1. Alier K, Ma L, Yang J, Westaway D, Jhamandas JH, (2011) Aβ inhibition of ionic conductance in mouse basal forebrain neurons is dependent upon the cellular prion protein PrPC. J Neurosci 31: 16292-16297.
2. Alzualde A, Indakoetxea B, Ferrer I, Moreno F, Barandiaran M, Gorostidi A, et al (2010) A novel PRNP Y218N mutation in Gerstmann-Straussler-Scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol 69: 789-800.
3. Baron GS, Hughson AG, Raymond GJ, Offerdahl DK, Barton KA, Raymond LD, et al (2011) Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra. Biochemistry 50: 4479-4490.
4. Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, et al (2011) Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci 31: 7259-7263.
5. Bate C, Williams A, (2011) Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins. J Biol Chem 286: 37955-37963.
6. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, et al (2007) Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 26: 538-547.
7. Beck JA, Mead S, Campbell TA, Dickinson A, Wientjens DP, Croes EA, et al (2001) Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology 57: 354-356.
8. Beland M, Motard J, Barbarin A, Roucou X, (2012) PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J Neurosci 32: 13255-13263.
9. Bessen RA, Marsh RF, (1992) Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 73: 329-334.
10. Bishop MT, Will RG, Manson JC, (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 107: 12005-12010.
11. Bolton DC, McKinley MP, Prusiner SB, (1982) Identification of a protein that purifies with the scrapie prion. Science 218: 1309-1311.
12. Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, et al (2003) Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362: 128-130.
13. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, et al (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379: 339-343.
14. Brandner S, Whitfield J, Boone K, Puwa A, O'Malley C, Linehan JM, et al (2008) Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philos Trans R Soc Lond B Biol Sci 363: 3755-3763.
15. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al (1997) The cellular prion protein binds copper in vivo. Nature 390: 684-687.
16. Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18: 901-907.
17. Bruce ME, (1993) Scrapie strain variation and mutation. Br Med Bull 49: 822-838.
18. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al (1997) Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389: 498-501.
19. Caetano FA, Beraldo FH, Hajj GN, Guimaraes AL, Jurgensen S, Wasilewska-Sampaio AP, et al (2011) Amyloid-beta oligomers increase the localization of prion protein at the cell surface. J Neurochem 117: 538-553.
20. Calzolai L, Lysek DA, Perez DR, Guntert P, Wuthrich K, (2005) Prion protein NMR structures of chickens, turtles, and frogs. Proc Natl Acad Sci U S A 102: 651-655.
21. Capellari S, Parchi P, Wolff BD, Campbell J, Atkinson R, Posey DM, et al (2002) Creutzfeldt-Jakob disease associated with a deletion of two repeats in the prion protein gene. Neurology 59: 1628-1630.
22. Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P, (2011) Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 121: 21-37.
23. Chakrabarti O, Hegde RS, (2009) Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegeneration. Cell 137: 1136-1147.
24. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, et al (1985) Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315: 331-333.
25. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, et al (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308: 1435-1439.
26. Chiesa R, Piccardo P, Ghetti B, Harris DA, (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 2: 1339-1351.
27. Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, et al (2010) Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci 11: 130.
28. Collinge J, Clarke AR, (2007) A general model of prion strains and their pathogenicity. Science 318: 930-936.
29. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF, (1996) Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383: 685-690.
30. DeArmond SJ, Qiu Y, Sanchez H, Spilman PR, Ninchak-Casey A, Alonso D, Daggett V, (1999) PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol 58: 1000-1009.
31. DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, et al (1997) Selective neuronal targeting in prion disease. Neuron 19: 1337-1348.
32. del Pino P, Weiss A, Bertsch U, Renner C, Mentler M, Grantner K, et al (2007) The configuration of the Cu2+ binding region in full-length human prion protein. Eur Biophys J 36: 239-252.
33. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S, (2012) Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 109: 8546-8551.
34. Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J, et al (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A 109: E1938-E1946.
35. Denkers ND, Hayes-Klug J, Anderson KR, Seelig DM, Haley NJ, Dahmes SJ, et al (2012) Aerosol transmission of chronic wasting disease in white-tailed deer. J Virol 87: 1890-1892.
36. Dickinson AG, Mackay JM, (1964) Genetical control of the incubation period in mice of the neurological disease, scrapie. Heredity (Edinb) 19: 279-288.
37. Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J, (1991) CJD discrepancy. Nature 353: 801-802.
38. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, Cohen FE, et al (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A 94: 13452-13457.
39. Endo T, Groth D, Prusiner SB, Kobata A, (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28: 8380-8388.
40. Flechsig E, Hegyi I, Leimeroth R, Zuniga A, Rossi D, Cozzio A, et al (2003) Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. EMBO J 22: 3095-3101.
41. Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, et al (2011) Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun 2: 336.
42. Gabriel JM, Oesch B, Kretzschmar H, Scott M, Prusiner SB, (1992) Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci U S A 89: 9097-9101.
43. Gajdusek DC, Gibbs CJ, Alpers M, (1966) Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209: 794-796.
44. Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, et al (2008) A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 63: 697-708.
45. Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E, (1995) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 5: 43-51.
46. Ghetti B, Tagliavini F, Giaccone G, Bugiani O, Frangione B, Farlow MR, Dlouhy SR, (1994) Familial Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 8: 41-48.
47. Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, et al (1989) Gerstmann-Straussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39: 1453-1461.
48. Giaccone G, Di Fede G, Mangieri M, Limido L, Capobianco R, Suardi S, et al (2007) A novel phenotype of sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 78: 1379-1382.
49. Gilmore R, Blobel G, Walter P, (1982) Protein translocation across the endoplasmic reticulum. I. Detection in the microsomal membrane of a receptor for the signal recognition particle. J Cell Biol 95: 463-469.
50. Gilmore R, Walter P, Blobel G, (1982) Protein translocation across the endoplasmic reticulum. II. Isolation and characterization of the signal recognition particle receptor. J Cell Biol 95: 470-477.
51. Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, Strittmatter SM, (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30: 6367-6374.
52. Guerrero D, Martinez-Velilla N, Caballero MC, Mendioroz MT, Tunon T, Masdeu J, et al (2008) A patient with MV2 subtype of sporadic Creutzfeldt-Jakob disease and atypical clinical presentation. Clin Neuropathol 27: 408-413.
53. Hainfellner JA, Liberski PP, Guiroy DC, Cervenakova L, Brown P, Gajdusek DC, Budka H, (1997) Pathology and immunocytochemistry of a kuru brain. Brain Pathol 7: 547-553.
54. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, Tarentino A, et al (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 274: 1-13.
55. Harris DA, Falls DL, Johnson FA, Fischbach GD, (1991) A prion-like protein from chicken brain copurifies with an acetylcholine receptor-inducing activity. Proc Natl Acad Sci U S A 88: 7664-7668.
56. Head MW, Knight R, Zeidler M, Yull H, Barlow A, Ironside JW, (2009) A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 35: 628-632.
57. Head MW, Lowrie S, Chohan G, Knight R, Scoones DJ, Ironside JW, (2010) Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, α synuclein and Aβ pathology. Acta Neuropathol 120: 821-823.
58. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, et al (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279: 827-834.
59. Helenius A, Aebi M, (2001) Intracellular functions of N-linked glycans. Science 291: 2364-2369.
60. Heller U, Winklhofer KF, Heske J, Reintjes A, Tatzelt J, (2003) Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J Biol Chem 278: 36139-36147.
61. Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, et al (1999) Evidence of presynaptic location and function of the prion protein. J Neurosci 19: 8866-8875.
62. Heske J, Heller U, Winklhofer KF, Tatzelt J, (2004) The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J Biol Chem 279: 5435-5443.
63. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, et al (1997) The same prion strain causes vCJD and BSE. Nature 389: 448-450.
64. Ironside JW, (2012) Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol 50: 50-56.
65. Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW, (2002) Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 110: 79-87.
66. Ishida C, Kakishima A, Okino S, Furukawa Y, Kano M, Oda Y, et al (2003) Sporadic Creutzfeldt-Jakob disease with MM1-type prion protein and plaques. Neurology 60: 514-517.
67. Jansen C, Head MW, van, Gool WA, Baas F, Yull H, Ironside JW, Rozemuller AJ, (2010) The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry 81: 1052-1055.
68. Juanes ME, Elvira G, Garcia-Grande A, Calero M, Gasset M, (2009) Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation. J Biol Chem 284: 2787-2794.
69. Kaski D, Mead S, Hyare H, Cooper S, Jampana R, Overell J, et al (2009) Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 374: 2128.
70. Kiachopoulos S, Heske J, Tatzelt J, Winklhofer KF, (2004) Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic 5: 426-436.
71. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, et al (2010) Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285: 14083-14087.
72. Kobayashi A, Arima K, Ogawa M, Murata M, Fukuda T, Kitamoto T, (2008) Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients. Acta Neuropathol 116: 561-566.
73. Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, Kitamoto T, (2010) Experimental verification of a traceback phenomenon in prion infection. J Virol 84: 3230-3238.
74. Kopp N, Streichenberger N, Deslys JP, Laplanche JL, Chazot G, (1996) Creutzfeldt-Jakob disease in a 52-year-old woman with florid plaques. Lancet 348: 1239-1240.
75. Kornfeld R, Kornfeld S, (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54: 631-664.
76. Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, et al (2003) Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A 100: 4784-4789.
77. Korth C, Kaneko K, Prusiner SB, (2000) Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains. J Gen Virol 81: 2555-2563.
78. Kramer ML, Kratzin HD, Schmidt B, Romer A, Windl O, Liemann S, et al (2001) Prion protein binds copper within the physiological concentration range. J Biol Chem 276: 16711-16719.
79. Krebs B, Bader B, Klehmet J, Grasbon-Frodl E, Oertel WH, Zerr I, et al (2007) A novel subtype of Creutzfeldt-Jakob disease characterized by a small 6 kDa PrP fragment. Acta Neuropathol 114: 195-199.
80. Kretzschmar HA, Sethi S, Foldvari Z, Windl O, Querner V, Zerr I, Poser S, (2003) Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol 13: 245-249.
81. Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ, (1986) Molecular cloning of a human prion protein cDNA. DNA 5: 315-324.
82. Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H, et al (2007) Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26: 175-188.
83. Kuczius T, Groschup MH, (1999) Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol Med 5: 406-418.
84. Kuczius T, Haist I, Groschup MH, (1998) Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation. J Infect Dis 178: 693-699.
85. Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, et al (2012) Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Hum Mol Genet 21: 1138-1144.
86. Laplanche JL, Delasnerie-Laupretre N, Brandel JP, Chatelain J, Beaudry P, Alperovitch A, Launay JM, (1994) Molecular genetics of prion diseases in France. French Research Group on epidemiology of human spongiform encephalopathies. Neurology 44: 2347-2351.
87. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM, (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457: 1128-1132.
88. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB, (2004) Synthetic mammalian prions. Science 305: 673-676.
89. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB, (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 103: 19105-19110.
90. Lehmann S, Harris DA, (1997) Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem 272: 21479-21487.
91. Lewis PA, Tattum MH, Jones S, Bhelt D, Batchelor M, Clarke AR, et al (2006) Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J Gen Virol 87: 2443-2449.
92. Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA, (2007) Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J 26: 548-558.
93. Lund C, Olsen CM, Skogtvedt S, Tveit H, Prydz K, Tranulis MA, (2009) Alternative translation initiation generates cytoplasmic sheep prion protein. J Biol Chem 284: 19668-19678.
94. Lysek DA, Schorn C, Nivon LG, Esteve-Moya V, Christen B, Calzolai L, et al (2005) Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci U S A 102: 640-645.
95. Ma J, Lindquist S, (2002) Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298: 1785-1788.
96. Ma J, Wollmann R, Lindquist S, (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298: 1781-1785.
97. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, et al (2010) Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 119: 177-187.
98. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J, (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302: 871-874.
99. Marella M, Lehmann S, Grassi J, Chabry J, (2002) Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem 277: 25457-25464.
100. McLean CA, (2008) Review. The neuropathology of kuru and variant Creutzfeldt-Jakob disease. Philos Trans R Soc Lond B Biol Sci 363: 3685-3687.
101. McLean CA, Ironside JW, Alpers MP, Brown PW, Cervenakova L, Anderson RM, Masters CL, (1998) Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 8: 429-437.
102. McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, et al (2004) Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165: 227-235.
103. Mead S, Joiner S, Desbruslais M, Beck JA, O'Donoghue M, Lantos P, et al (2007) Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman. Arch Neurol 64: 1780-1784.
104. Mead S, Poulter M, Uphill J, Beck J, Whitfield J, Webb TE, et al (2009) Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 8: 57-66.
105. Mead S, Uphill J, Beck J, Poulter M, Campbell T, Lowe J, et al (2012) Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. Hum Mol Genet 21: 1897-1906.
106. Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Campbell T, et al (2009) A novel protective prion protein variant that colocalizes with kuru exposure. N Engl J Med 361: 2056-2065.
107. Meyer DI, Dobberstein B, (1980) Identification and characterization of a membrane component essential for the translocation of nascent proteins across the membrane of the endoplasmic reticulum. J Cell Biol 87: 503-508.
108. Mitteregger G, Vosko M, Krebs B, Xiang W, Kohlmannsperger V, Nolting S, et al (2007) The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol 17: 174-183.
109. Moore RA, Vorberg I, Priola SA, (2005) Species barriers in prion diseases-brief review. Arch Virol Suppl 19: 187-202.
110. Muramoto T, DeArmond SJ, Scott M, Telling GC, Cohen FE, Prusiner SB, (1997) Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nat Med 3: 750-755.
111. Notari S, Capellari S, Giese A, Westner I, Baruzzi A, Ghetti B, et al (2004) Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 279: 16797-16804.
112. Nunziante M, Gilch S, Schatzl HM, (2003) Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein. J Biol Chem 278: 3726-3734.
113. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R, et al (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735-746.
114. Palmer MS, Dryden AJ, Hughes JT, Collinge J, (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340-342.
115. Palmer MS, Mahal SP, Campbell TA, Hill AF, Sidle KC, Laplanche JL, Collinge J, (1993) Deletions in the prion protein gene are not associated with CJD. Hum Mol Genet 2: 541-544.
116. Panegyres PK, Toufexis K, Kakulas BA, Cernevakova L, Brown P, Ghetti B, et al (2001) A new PRNP mutation (G131V) associated with Gerstmann-Straussler- Scheinker disease. Arch Neurol 58: 1899-1902.
117. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, et al (1997) Typing prion isoforms. Nature 386: 232-234.
118. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39: 767-778.
119. Parchi P, Cescatti M, Notari S, Schulz-Schaeffer WJ, Capellari S, Giese A, et al (2010) Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 133: 3030-3042.
120. Parchi P, Chen SG, Brown P, Zou W, Capellari S, Budka H, et al (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci U S A 95: 8322-8327.
121. Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P, et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124: 517-529.
122. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224-233.
123. Parchi P, Notari S, Weber P, Schimmel H, Budka H, Ferrer I, et al (2009) Inter-laboratory assessment of PrPSc typing in Creutzfeldt-Jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol 19: 384-391.
124. Parchi P, Strammiello R, Giese A, Kretzschmar H, (2011) Phenotypic variability of sporadic prion disease and its molecular basis: past, present, future. Acta Neuropathol 121: 91-112.
125. Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A, et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118: 659-671.
126. Parodi AJ, (2000) Protein glucosylation and its role in protein folding. Annu Rev Biochem 69: 69-93.
127. Pattison IH, Millson GC, (1961) Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 71: 101-109.
128. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, Prusiner SB, (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10: 854-863.
129. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, et al (2002) A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34: 921-932.
130. Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, DeArmond SJ, et al (2002) Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A 99: 13079-13084.
131. Peters PJ, Mironov A, Jr, Peretz D, van, Donselaar E, Leclerc E, Erpel S, et al (2003) Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 162: 703-717.
132. Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, Nochlin D, et al (1998) Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57: 979-988.
133. Priola SA, Lawson VA, (2001) Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J 20: 6692-6699.
134. Prusiner SB, (1989) Scrapie prions. Annu Rev Microbiol 43: 345-374.
135. Prusiner SB, (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336: 1511-1513.
136. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE, (1984) Purification and structural studies of a major scrapie prion protein. Cell 38: 127-134.
137. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, et al (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673-686.
138. Puckett C, Concannon P, Casey C, Hood L, (1991) Genomic structure of the human prion protein gene. Am J Hum Genet 49: 320-329.
139. Qin K, Yang DS, Yang Y, Chishti MA, Meng LJ, Kretzschmar HA, et al (2000) Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J Biol Chem 275: 19121-19131.
140. Rambold AS, Miesbauer M, Rapaport D, Bartke T, Baier M, Winklhofer KF, Tatzelt J, (2006) Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol Biol Cell 17: 3356-3368.
141. Rambold AS, Muller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J, (2008) Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J 27: 1974-1984.
142. Rane NS, Yonkovich JL, Hegde RS, (2004) Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J 23: 4550-4559.
143. Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Muller V, Krishnan R, et al (2011) The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J 30: 2057-2070.
144. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wuthrich K, (1996) NMR structure of the mouse prion protein domain PrP(121-321). Nature 382: 180-182.
145. Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K, (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413: 282-288.
146. Rodriguez-Martinez AB, Garrido JM, Zarranz JJ, Arteagoitia JM, de, Pancorbo MM, Atares B, et al (2010) A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: case report. BMC Neurol 10: 99.
147. Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, et al (1999) Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 96: 13044-13049.
148. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4: 1157-1165.
149. Sanchez-Juan P, Bishop MT, Aulchenko YS, Brandel JP, Rivadeneira F, Struchalin M, et al (2012) Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk. Neurobiol Aging 33: 1487. e21-8.
150. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J, (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470: 540-542.
151. Saunders SE, Bartelt-Hunt SL, Bartz JC, (2012) Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis 18: 369-376.
152. Schatzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB, (1995) Prion protein gene variation among primates. J Mol Biol 245: 362-374.
153. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, et al (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314: 1209-1225.
154. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, et al (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847-857.
155. Scott MR, Safar J, Telling G, Nguyen O, Groth D, Torchia M, et al (1997) Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc Natl Acad Sci U S A 94: 14279-14284.
156. Scott MR, Supattapone S, Nguyen HO, DeArmond SJ, Prusiner SB, (2000) Transgenic models of prion disease. Arch Virol Suppl 16: 113-124.
157. Scott MR, Will R, Ironside J, Nguyen HO, Tremblay P, DeArmond SJ, Prusiner SB, (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A 96: 15137-15142.
158. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T, (1998) Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 43: 826-828.
159. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T, (1998) Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Lancet 351: 419.
160. Shimizu S, Hoshi K, Muramoto T, Homma M, Ironside JW, Kuzuhara S, et al (1999) Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 56: 357-362.
161. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, et al (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93: 203-214.
162. Shyng SL, Heuser JE, Harris DA, (1994) A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol 125: 1239-1250.
163. Shyng SL, Moulder KL, Lesko A, Harris DA, (1995) The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J Biol Chem 270: 14793-14800.
164. Simonic T, Duga S, Strumbo B, Asselta R, Ceciliani F, Ronchi S, (2000) cDNA cloning of turtle prion protein. FEBS Lett 469: 33-38.
165. Soldevila M, Calafell F, Andres AM, Yague J, Helgason A, Stefansson K, Bertranpetit J, (2003) Prion susceptibility and protective alleles exhibit marked geographic differences. Hum Mutat 22: 104-105.
166. Stahl N, Borchelt DR, Hsiao K, Prusiner SB, (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51: 229-240.
167. Stewart P, Campbell L, Skogtvedt S, Griffin KA, Arnemo JM, Tryland M, et al (2012) Genetic predictions of prion disease susceptibility in carnivore species based on variability of the prion gene coding region. PLoS ONE 7: e50623.
168. Stewart RS, Piccardo P, Ghetti B, Harris DA, (2005) Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci 25: 3469-3477.
169. Stimson E, Hope J, Chong A, Burlingame AL, (1999) Site-specific characterization of the N-linked glycans of murine prion protein by
170. Strumbo B, Ronchi S, Bolis LC, Simonic T, (2001) Molecular cloning of the cDNA coding for Xenopus laevis prion protein. FEBS Lett 508: 170-174.
171. Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, et al (2003) The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 22: 3591-3601.
172. Takashima S, Tateishi J, Taguchi Y, Inoue H, (1997) Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet 350: 865-866.
173. Tamguney G, Richt JA, Hamir AN, Greenlee JJ, Miller MW, Wolfe LL, et al (2012) Salivary prions in sheep and deer. Prion 6: 52-61.
174. Taraboulos A, Rogers M, Borchelt DR, McKinley MP, Scott M, Serban D, Prusiner SB, (1990) Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc Natl Acad Sci U S A 87: 8262-8266.
175. Telling GC, (2011) Transgenic mouse models and prion strains. Top Curr Chem 305: 79-99.
176. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274: 2079-2082.
177. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, et al (2012) Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15: 1227-1235.
178. van Rheede T, Smolenaars MM, Madsen O, de, Jong WW, (2003) Molecular evolution of the mammalian prion protein. Mol Biol Evol 20: 111-121.
179. Wadsworth JD, Asante EA, Collinge J, (2010) Review: contribution of transgenic models to understanding human prion disease. Neuropathol Appl Neurobiol 36: 576-597.
180. Wadsworth JD, Joiner S, Linehan JM, Desbruslais M, Fox K, Cooper S, et al (2008) Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A 105: 3885-3890.
181. Walter P, Blobel G, (1980) Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum. Proc Natl Acad Sci U S A 77: 7112-7116.
182. Walter P, Blobel G, (1982) Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum. Nature 299: 691-698.
183. Walter P, Gilmore R, Blobel G, (1984) Protein translocation across the endoplasmic reticulum. Cell 38: 5-8.
184. Wang F, Wang X, Yuan CG, Ma J, (2010) Generating a prion with bacterially expressed recombinant prion protein. Science 327: 1132-1135.
185. Wang X, Bowers SL, Wang F, Pu XA, Nelson RJ, Ma J, (2009) Cytoplasmic prion protein induces forebrain neurotoxicity. Biochim Biophys Acta 1792: 555-563.
186. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, Prusiner SB, (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51: 651-662.
187. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921-925.
188. Wilson R, Plinston C, Hunter N, Casalone C, Corona C, Tagliavini F, et al (2012) Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J Gen Virol 93: 1624-1629.
189. Windl O, Dempster M, Estibeiro JP, Lathe R, de, Silva R, Esmonde T, et al (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98: 259-264.
190. Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, et al (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105: 244-252.
191. Winklhofer KF, Heller U, Reintjes A, Tatzelt J, (2003) Inhibition of complex glycosylation increases the formation of PrPsc. Traffic 4: 313-322.
192. Wopfner F, Weidenhofer G, Schneider R, von, Brunn A, Gilch S, Schwarz TF, et al (1999) Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 289: 1163-1178.
193. Wu Y, Brown WT, Robakis NK, Dobkin C, Devine-Gage E, Merz P, Wisniewski HM, (1987) A PvuII RFLP detected in the human prion protein (PrP) gene. Nucleic Acids Res 15: 3191.
194. Yamada M, Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Kitamoto T, Sato T, et al (2009) Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes. Neuropathology 29: 609-618.
195. You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, Xia P, et al (2012) Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 109: 1737-1742.
196. Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, et al (2010) Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 68: 162-172.
197. Zuegg J, Gready JE, (2000) Molecular dynamics simulation of human prion protein including both N-linked oligosaccharides and the GPI anchor. Glycobiology 10: 959-974.